Jord BioScience, a science and analytics company specializing in customizable microbial solutions for agriculture, has successfully closed its Series B funding round. This latest investment will accelerate the company’s mission to develop and commercialize cutting-edge microbial technologies designed to enhance crop inputs and bolster sustainable farming practices.
The funding round was led by Silver Blue LLC, a Maryland-based investment firm focused on agrifood technology. Other key investors include Discovery Capital Funding, a program that provides matching equity investments for companies affiliated with the University of Minnesota, as well as Minnesota’s Small Business Credit Initiative (SSBCI) Direct Investment and existing stakeholders. The infusion of capital marks a critical step forward for Jord BioScience, providing the financial runway to scale its operations and drive broader adoption of its microbial solutions.
“This funding round marks a significant milestone for Jord BioScience, validating our partnership approach and the true potential of our microbial solutions to transform agriculture,” said Dr. Keri Carstens, president and CEO of Jord BioScience. “With this investment, we’re poised to scale our operations to help biologicals and crop input companies accelerate product discovery and innovation for farmers worldwide.”
At the core of Jord BioScience’s innovation is its expansive microbial bank, an unparalleled collection of more than 6,500 microbial isolates sourced from diverse global soils. This vast repository, developed over more than 30 years of research by the company’s Chief Science Officer, Dr. Linda Kinkel, serves as a foundation for advanced microbial solutions that enhance, protect, and promote crop performance. By harnessing the natural diversity of microbes from various ecosystems, Jord BioScience offers unique, science-backed solutions that improve the consistency and efficacy of biological inputs for major crops such as corn, soybeans, canola, and wheat, as well as specialty crops.
The investment comes at a time when agricultural companies are increasingly turning to biological solutions as a means to boost productivity while mitigating environmental impact. With mounting regulatory scrutiny on synthetic inputs and growing concerns over soil health, the demand for reliable microbial-based alternatives has surged. Jord BioScience aims to bridge the gap between research and commercial application by streamlining product differentiation, life cycle management, and revenue generation for companies in the agricultural sector.
“While biological innovation continues to evolve, Jord BioScience stands out by offering a fast and cost-effective approach to product differentiation, life cycle management, and revenue generation for agricultural companies,” said Francis Goelet, director of Silver Blue LLC. “We believe Jord’s technology can bring improved consistency of performance to the biological industry at a time when farmers are under pressure to produce more food while navigating financial and environmental pressures. We look forward to seeing the positive impact of Jord BioScience as the company continues to grow.”
The Series B funding not only reinforces investor confidence in Jord BioScience’s approach but also signals a broader shift in the agricultural industry toward science-driven, sustainable alternatives. With the financial backing to expand its reach, Jord BioScience is well-positioned to accelerate product discovery, support agribusiness partners, and drive the next wave of innovation in microbial solutions for global agriculture.
Comments